Literature DB >> 12027527

Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.

S I Ahmad1.   

Abstract

Post-burn microbial infections are a major problem in recovering from the trauma of third-degree burns, and the survival of patients can depend upon the severity of the burn and the infections encountered. Within 24 hours, patients can start suffering from opportunistic bacterial attacks, which can vary from simple infection, such as those easily treatable by antibiotics, to more complicated types, which may have natural or acquired resistance to drugs. Infection by multiple drug-resistant bacteria can create additional complexity to the problem. As an alternative to treating bacterial infections by antibiotics, bacteriophages have been in use in certain parts of the world, such as at Tbilisi in Georgia and in Poland, and this approach has now been more widely recognized. Results have shown that phage therapy has an 80% success rate against Enterococcus infections and up to 90% against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae. Here it is proposed that bacteriophages can effectively be used for the treatment of post-burn infections, particularly the ubiquitous opportunistic pathogens, Pseudomonas spp., known to be notoriously resistant to a variety of antibiotics. This kind of treatment may be of particular importance in Third World countries where the incidence of burns and infections, due to lack of stringent safety regulations and proper hygiene respectively, may be more common and where cocktails of antibiotics may be less affordable. Phages that can possibly be employed in the treatment and their advantages compared to the use of antibiotics are also highlighted. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027527     DOI: 10.1054/mehy.2001.1522

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

1.  Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.

Authors:  Birendra R Tiwari; Shukho Kim; Marzia Rahman; Jungmin Kim
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

2.  Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli.

Authors:  Minsik Kim; Sangryeol Ryu
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

3.  Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.

Authors:  Catherine S McVay; Marisela Velásquez; Joe A Fralick
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

4.  Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice.

Authors:  Chih-Hsin Hung; Chih-Feng Kuo; Chiou-Huey Wang; Ching-Ming Wu; Nina Tsao
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

5.  Bacteriophage: laboratorial diagnosis and phage therapy.

Authors:  Joas L Da Silva; Rosario D C Hirata; Mario H Hirata
Journal:  Braz J Microbiol       Date:  2009-09-01       Impact factor: 2.476

Review 6.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

Review 7.  Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review.

Authors:  Preeti Pachori; Ragini Gothalwal; Puneet Gandhi
Journal:  Genes Dis       Date:  2019-04-17

8.  Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019.

Authors:  Guoliang Liu; Mingzhao Qin
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-16       Impact factor: 2.650

9.  A theoretical and experimental proteome map of Pseudomonas aeruginosa PAO1.

Authors:  Elke Lecoutere; Peter Verleyen; Steven Haenen; Katrien Vandersteegen; Jean-Paul Noben; Johan Robben; Liliane Schoofs; Pieter-Jan Ceyssens; Guido Volckaert; Rob Lavigne
Journal:  Microbiologyopen       Date:  2012-06       Impact factor: 3.139

10.  Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.

Authors:  Gabriela Trigo; Teresa G Martins; Alexandra G Fraga; Adhemar Longatto-Filho; António G Castro; Joana Azeredo; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.